vimarsana.com

Page 3 - சீரம் நிறுவனம் ஆஃப் இந்தியா பிரைவேட் லிமிடெட் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Mass Covid vaccination drive likely to resumes in July

Mass Covid vaccination drive likely to resumes in July
banglamirrornews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from banglamirrornews.com Daily Mail and Mail on Sunday newspapers.

Vacciine drive: SII distances itself from statement of executive director | India News

NEW DELHI: The Serum Institute has dissociated itself from its executive director’s statement that the government began the Covid-19 vaccination of multiple age groups without taking into consideration the available stock, stating that this is “not the view of the company”. In a letter to the health ministry on May 22, Prakash Kumar Singh, director of government and regulatory affairs at the Pune-based Serum Institute of India (SII), clarified that the statement by its executive director Suresh Jadav at a recent event is not the view of the company, sources said. “On behalf of our CEO Adar C Poonawalla, I want to inform you that this statement is not issued on behalf of SIIPL (Serum Institute of India Pvt Ltd) and the company completely dissociates itself from this statement. this is not the view of the company at all.

Vaccine shortage attributed to India s expanded coverage for wider population: Experts

Petition in Supreme Court Seeks Data From Vaccines Clinical Trials

Petition in Supreme Court Seeks Data From Vaccines’ Clinical Trials Jacob Puliyel has submitted that there’s no reason the data from clinical trials needs to be hidden from public view. A medical worker holds a bottle of AstraZeneca s COVID-19 vaccine at a vaccination centre in Kuala Lumpur, Malaysia May 5, 2021 in this file photo. Photo: Reuters/Lim Huey Teng Law21 hours ago Jacob Puliyel, a former member of the National Technical Advisory Group on Immunisation, has filed a public interest litigation (PIL) petition in the Supreme Court seeking segregated data from the clinical trials for the vaccines that are part of the Indian government’s ongoing COVID-19 vaccination drive.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.